Bioxcel Therapeutics, INC. (BTAI) — DEF 14A Filings
All DEF 14A filings from Bioxcel Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
BioXcel Therapeutics Files Definitive Proxy Statement
— Dec 30, 2024 Risk: low
BioXcel Therapeutics, Inc. filed its definitive proxy statement on December 30, 2024, for its annual meeting of stockholders scheduled for January 28, 2025. The -
BioXcel Therapeutics Announces 2024 Annual Meeting of Stockholders
— Apr 29, 2024 Risk: low
BioXcel Therapeutics, Inc. (BTAI) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. The 2024 annual meeting of stockholders for BioXcel Therapeu
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX